Skip to content
TWST·Nasdaq·US

Twist Bioscience

Twist Bioscience develops and sells synthetic DNA products, including genes, oligo pools, and NGS tools, using a proprietary silicon-based DNA synthesis platform. It also sells antibody discovery and biopharma solutions that support drug discovery and development, with a substantial revenue base in NGS applications for research and diagnostics.

Recent Activity

Updated Sep 24, 2026
–Twist Bioscience is expanding its exposure to AI-driven drug discovery through a partnership with Lilly's TuneLab platform.

Past updates are part of the Pro plan.

Thematic Position

TWST

Relationship Groups

Suppliers1
Customers3
Partners4
Competitors7

Relationship details are part of the Pro plan.

Ended Relationships

2 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

export controlregulatory compliance
Twist Bioscience must comply with evolving EU and international regulatory requirements
SEC 10-QFeb 26, 2026

The full regulatory passage is part of the Pro plan.

2 more · Regulatory and geopolitical insights are part of the Pro plan.